The company's bioprinter utilizes biomaterials, biodegradable polymers, hydrogels, and ECM-derived proteins to create tissue structures, allowing medical researchers to study regenerative treatment and replicate cancer tissue characteristics. Founded in 2015, Pensées Inc. is a Korean biotech start-up that offers advanced 3D cell culture solutions, expanding its application areas to brain/liver organoids and cultivated meat.